106 related articles for article (PubMed ID: 9930074)
21. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
22. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.
Sandadi S; Tanner EJ; Khoury-Collado F; Kostolias A; Makker V; Chi DS; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Mar; 23(3):553-8. PubMed ID: 23392402
[TBL] [Abstract][Full Text] [Related]
23. Impact of histology on prognosis of patients with early-stage cervical cancer treated with radical surgery.
Rudtanasudjatum K; Charoenkwan K; Khunamornpong S; Siriaunkgul S
Int J Gynaecol Obstet; 2011 Nov; 115(2):183-7. PubMed ID: 21885048
[TBL] [Abstract][Full Text] [Related]
24. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
25. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
[TBL] [Abstract][Full Text] [Related]
26. Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma.
Schlenger K; Höckel M; Mitze M; Schäffer U; Weikel W; Knapstein PG; Lambert A
Gynecol Oncol; 1995 Oct; 59(1):57-66. PubMed ID: 7557616
[TBL] [Abstract][Full Text] [Related]
27. Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
In Choi J; Chang HK; Lee DW; Lee KH; Park JS; Lee HN
Gynecol Oncol; 2015 Nov; 139(2):319-23. PubMed ID: 26360017
[TBL] [Abstract][Full Text] [Related]
28. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
Hanprasertpong J; Jiamset I; Atjimakul T
Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
[TBL] [Abstract][Full Text] [Related]
30. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
Kinugasa M; Nishimura R; Koizumi T; Morisue K; Higashida T; Natazuka T; Nakagawa T; Isobe T; Baba S; Hasegawa K
Jpn J Cancer Res; 1995 Aug; 86(8):783-9. PubMed ID: 7559103
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
32. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of combined serum biomarkers in predicting outcomes in cervical cancer patients.
Li J; Cheng H; Zhang P; Dong Z; Tong HL; Han JD; Guo F; Tian YP
Clin Chim Acta; 2013 Sep; 424():292-7. PubMed ID: 23850705
[TBL] [Abstract][Full Text] [Related]
34. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
35. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
[TBL] [Abstract][Full Text] [Related]
38. Cervical Cancer in Women Aged 35 Years and Younger.
Pelkofski E; Stine J; Wages NA; Gehrig PA; Kim KH; Cantrell LA
Clin Ther; 2016 Mar; 38(3):459-66. PubMed ID: 26899314
[TBL] [Abstract][Full Text] [Related]
39. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
[TBL] [Abstract][Full Text] [Related]
40. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]